The notices it replaced
- Reissues: PAR-21-035 Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required)
- 2 steps back: PAR-18-559 Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required)
Replaced by PAR-25-167.
Who won it before
288 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $193,123,431 in first-year total cost, median $660,423.
Most frequent study sections
- Cancer Prevention Study Section[CPSS]23
- Interventions to Prevent and Treat Addictions Study Section[IPTA]21
- Biobehavioral Medicine and Health Outcomes Study Section[BMHO]20
- Interdisciplinary Clinical Care in Specialty Care Settings Study Section[ICSC]18
- Health Services: Quality and Effectiveness Study Section[HSQE]14
Most frequent institutions
- MASSACHUSETTS GENERAL HOSPITAL14
- UNIVERSITY OF TX MD ANDERSON CAN CTR12
- SLOAN-KETTERING INST CAN RESEARCH10
- DUKE UNIVERSITY9
- MEDICAL UNIVERSITY OF SOUTH CAROLINA9
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2025 | Evaluating the Impact of Accessible and Scalable Digital Interventions to Address Co-Occurring Insomnia and Depression in Breast Cancer Survivors Using an Adaptive Design1R01CA295673-01A1 | CHOW, PHILIP | UNIVERSITY OF VIRGINIA, VA | $3,355,681 | MESH |
| 2025 | Remotely-Delivered Cognitive Behavioral Stress Management Effects on Cancer-Accelerated Aging in Older, Distressed Breast Cancer Survivors1R01CA296071-01A1 | ANTONI, MICHAEL HOWARD | UNIVERSITY OF MIAMI CORAL GABLES, FL | $2,746,080 | BMHO |
| 2025 | A Clinical Trial of Cancer Prevention by Biomarker Based Detections of Barrett's Esophagus and Its Progression1R01CA295877-01 | CHAK, AMITABHMARKOWITZ, SANFORD D.WILLIS, JOSEPH EDWARD | CASE WESTERN RESERVE UNIVERSITY, OH | $1,623,261 | CPSS |
| 2025 | Randomized Trial of a Targeted Palliative Care Intervention for Patients with Metastatic Breast Cancer1R01CA299956-01 | TEMEL, JENNIFER SUE | MASSACHUSETTS GENERAL HOSPITAL, MA | $858,166 | ICSC |
| 2025 | A randomized trial of cardioprotective strategies in newly diagnosed diffuse large B-cell lymphoma and pre-existing cardiomyopathy or prior anthracycline exposure1R37CA300969-01 | UPSHAW, JENICA | BETH ISRAEL DEACONESS MEDICAL CENTER, MA | $818,625 | ZRG1 |
| 2025 | Thriving Beyond Treatment: A Resilience-Based Approach to Improve Long-term Quality of Life in Post-treatment Lymphoma Survivorship1R37CA303094-01 | PEREZ-LOUGEE, GISELLE KATIRIA | MASSACHUSETTS GENERAL HOSPITAL, MA | $817,829 | ICSC |
| 2025 | Evaluation of Cardiovascular Health Outcomes among Survivors 2 (ECHOS-2)1R01CA297448-01A1 | EHRHARDT, MATTHEW JAMESWATERS, ERIKA A | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, TN | $772,418 | CMGC |
| 2025 | A Tailored Medication Adherence-Promotion Intervention for Adolescents and Young Adults with Cancer1R37CA302422-01 | MCGRADY, MEGHAN EILEEN | CINCINNATI CHILDRENS HOSP MED CTR, OH | $763,161 | CMGC |
| 2025 | Providing nicotine replacement therapy to enhance the efficacy of a smoking cessation smartphone app for Hispanic adults1R01CA298383-01 | BRICKER, JONATHAN B | FRED HUTCHINSON CANCER CENTER, WA | $757,913 | HPC |
| 2025 | A scalable cruciferous vegetable intervention to reduce bladder cancer recurrence and progression1R01CA296175-01 | TANG, LIYEARY, KAREN HYE-CHEON KIM | ROSWELL PARK CANCER INSTITUTE CORP, NY | $717,150 | LCBH |
| 2025 | The MIND-BC Study: MIND diet for Breast cancer Cognition1R01CA299480-01 | CROWDER, SYLVIA | H. LEE MOFFITT CANCER CTR & RES INST, FL | $713,235 | ZRG1 |
| 2025 | Algorithm-enabled Patients Activated in Cancer care through Teams (A-PACT) toimprove goals of care communication for people with cancer1R37CA296075-01 | MANZ, CHRISTOPHERPARIKH, RAVI BHARATPATEL, MANALI I | EMORY UNIVERSITY, GA | $708,091 | ZRG1 |
| 2025 | Youth Vaping Prevention through Immersive Technology1R01CA294027-01A1 | CAMENGA, DEEPA RHIEFTJE, KIMBERLY D | YALE UNIVERSITY, CT | $705,618 | HPC |
| 2025 | Practical Randomized Controlled Trial of Artificial Intelligence for Melanoma Diagnosis (PRACTA-MEL)1R01CA293974-01A1 | ROTEMBERG, VERONICA MIRIAM | SLOAN-KETTERING INST CAN RESEARCH, NY | $700,611 | CTIS |
| 2025 | Investigating Efficacious E-Cigarette Interventions and Cessation Effects on Cancer-Related Biomarkers: A Randomized Trial of Varenicline in Adults1R01CA296186-01 | FUCITO, LISA MTOLL, BENJAMIN ANDREW | YALE UNIVERSITY, CT | $687,995 | IPTA |
| 2025 | A randomized trial of charcoal-filtered cigarettes on product perceptions, smoking behaviors, and toxicant exposure1R37CA296976-01A1 | MERCINCAVAGE, MELISSA | RUTGERS BIOMEDICAL AND HEALTH SCIENCES, NJ | $687,511 | LHB |
| 2025 | Minimally Invasive Molecular Approaches for the Detection of Barrett’s Esophagus and Esophageal Adenocarcinoma2R01CA241164-07 | CHHATWAL, JAGPREETIYER, PRASAD G.KISIEL, JOHN | MAYO CLINIC ARIZONA, AZ | $678,428 | ZRG1 |
| 2025 | A decisional intervention for older adults with acute myeloid leukemia and their caregivers1R01CA288318-01A1 | LOH, KAH POH | UNIVERSITY OF ROCHESTER, NY | $678,204 | ICSC |
| 2025 | Improving Care Delivery for Individuals with Mental Illness and Cancer Across a Cancer Center Network.1R37CA300110-01 | IRWIN, KELLY EDWARDS | MASSACHUSETTS GENERAL HOSPITAL, MA | $673,096 | ICSC |
| 2025 | Supportive Tailored Exercise Program for Survivors of Breast Cancer (STEPS-BC)1R01CA290863-01A1 | HUNDLEY, WILLIAM GREGORY | VIRGINIA COMMONWEALTH UNIVERSITY, VA | $671,757 | CCHS |
| 2025 | Hybrid Type I Cluster Randomized Effectiveness-Implementation Trial of CARES1R01CA296402-01 | STEEL, JENNIFER L. | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | $669,324 | HSQE |
| 2025 | Weight management and Black American women: Targeting social networks as a strategy to improve outcomes1R01CA296842-01 | FITZGIBBON, MARIAN L.MOLINA, YAMILE | UNIVERSITY OF ILLINOIS AT CHICAGO, IL | $665,368 | LCBH |
| 2025 | Catalyzing Cigarette Smoking Cessation Through Harm Reduction Sampling Among People Unmotivated to Quit1R01CA302758-01 | AUDRAIN-MCGOVERN, JANET E | UNIVERSITY OF PENNSYLVANIA, PA | $663,554 | IPTA |
| 2025 | Proactive Outreach and Streamlined Genetic Testing in Prostate Cancer Survivors1R01CA296911-01A1 | KINNEY, ANITA Y.SCHWARTZ, MARC D | GEORGETOWN UNIVERSITY, DC | $663,383 | HSQE |
| 2025 | Moving Forward with Multiple Myeloma1R01CA300310-01 | D'SOUZA, ANITASHEEAN, PATRICIA MAUREENSTOLLEY, MELINDA R | MEDICAL COLLEGE OF WISCONSIN, WI | $657,844 | BMHO |
| 2025 | Randomized Trial of a Novel Approach to Addressing Fear of Progression in Advanced Cancer1R01CA300028-01A1 | ARCH, JOANNA J | UNIVERSITY OF COLORADO, CO | $656,046 | BMHO |
| 2025 | Interventions to Decrease Cancer Information Avoidance1R01CA276430-01A1 | OROM, HEATHER | STATE UNIVERSITY OF NEW YORK AT BUFFALO, NY | $637,596 | SPIP |
| 2025 | iC9-CAR.CSPG4 CAR-T Cells for Head and Neck Squamous Cell Carcinoma1R01CA296807-01 | WEISS, JARED | UNIV OF NORTH CAROLINA CHAPEL HILL, NC | $627,456 | CIC |
| 2025 | A Randomized Factorial Trial of Varenicline with Nicotine Lozenges and a Smartphone Medication Adherence Intervention to Promote Smoking Cessation1R01CA298165-01 | AHLUWALIA, JASJIT SINGHKENDZOR, DARLA ELIZABETH | UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR, OK | $625,201 | IPTA |
| 2025 | A Novel Harm Reduction Approach for Oncology Outpatients who Smoke and Refuse Traditional Tobacco Treatment1R01CA293735-01A1 | ROJEWSKI, ALANASMITH, TRACY TAYLOR | MEDICAL UNIVERSITY OF SOUTH CAROLINA, SC | $619,175 | IPTA |
| 2025 | Expanded Safety and Preliminary Efficacy of Adjuvant 5-Fluorouracil Following Thermal Ablation to Improve HPV Treatment Outcomes in Women with HIV in Africa1R37CA306827-01 | MUNGO, CHEMTAI | UNIV OF NORTH CAROLINA CHAPEL HILL, NC | $605,863 | HCAC |
| 2025 | Randomized Trial of a Multi-Disciplinary Intervention for Patients with Chronic Grant-Versus-Host Disease1R01CA296889-01 | EL-JAWAHRI, AREEJTRAEGER, LARA | UNIVERSITY OF MIAMI CORAL GABLES, FL | $599,339 | BMHO |
| 2025 | Using novel behavioral economic measures to characterize dual marijuana and tobacco use in young adults1R01CA289409-01A1 | ASTON, ELIZABETHCASSIDY, RACHEL N | BROWN UNIVERSITY, RI | $594,099 | ARM |
| 2025 | Efficacy of a multi-level intervention designed to promote adherence to WCRF/AICR dietary guidelines for cancer prevention1R01CA288323-01A1 | BUTRYN, MEGHAN | DREXEL UNIVERSITY, PA | $588,359 | LCBH |
| 2025 | Efficacy of a group-based videoconference intervention to increase physical activity in cancer survivors1R01CA296965-01 | LEACH, HEATHER JEAN | COLORADO STATE UNIVERSITY, CO | $414,446 | LCBH |
| 2024 | Comparative Effectiveness of Sequential Pharmacotherapeutic Strategies and Virtually Delivered Treatment to Optimize Smoking Cessation1R01CA278938-01A1 · under PAR-21-035 | CINCIRIPINI, PAUL MICHAELROBINSON, JASON D | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | $923,199 | IPTA |
| 2024 | Dual Use Cessation: A MOST Screening Trial to Identify Effective Interventions to Help People Who Smoke and Vape1R01CA290895-01 · under PAR-21-035 | BAKER, TIMOTHY BPIPER, MEGAN E | UNIVERSITY OF WISCONSIN-MADISON, WI | $876,297 | ZRG1 |
| 2024 | Decreasing Cardiometabolic Risk in Survivors of Childhood Cancer: Survivors engaged in Time-Restricted EatiNG after THerapy (STRENGTH)1R01CA286563-01A1 · under PAR-21-035 | FRIEDMAN, DANIELLE | SLOAN-KETTERING INST CAN RESEARCH, NY | $794,530 | ZRG1 |
| 2024 | AYA ACCESS Study: An enhanced eHealth and Chat-bot enabled delivery model for clinical genetic services in community AYA cancer patients1R01CA284748-01A1 · under PAR-21-035 | BRADBURY, ANGELA R.HENDERSON, TARA OLIVE | UNIVERSITY OF PENNSYLVANIA, PA | $754,398 | ZRG1 |
| 2024 | MedSupport: A Novel Multilevel Intervention to Identify and Address Barriers to Pediatric Medication1R01CA283501-01A1 · under PAR-21-035 | BOUCHARD, ELIZABETHKELLY, KARA M | ROSWELL PARK CANCER INSTITUTE CORP, NY | $754,264 | CMGC |
| 2024 | Randomized trial of REVITALIZE: A telehealth intervention to reduce fatigue interference among adults with advanced ovarian cancer on PARP inhibitors1R01CA289547-01 · under PAR-21-035 | ARCH, JOANNA JWRIGHT, ALEXI A | DANA-FARBER CANCER INST, MA | $748,174 | ICSC |
| 2024 | Enhanced Pain Coping in Cancer (EPIC)1R01CA285746-01A1 · under PAR-21-035 | GARLAND, ERIC LEEHANLEY, ADAM WESLEYMAO, JUN J | SLOAN-KETTERING INST CAN RESEARCH, NY | $732,536 | BMHO |
| 2024 | HEME-Hospice: An Intervention to improve Hospice Use for Patients with Hematologic Malignancies1R37CA289639-01 · under PAR-21-035 | ODEJIDE, OREOFE OLUKEMI | DANA-FARBER CANCER INST, MA | $731,526 | ICSC |
| 2024 | Optimizing Treatment of Co-occurring Smoking and Unhealthy Alcohol use among PWH in Nairobi, Kenya1R01CA288235-01A1 · under PAR-21-035 | HIMELHOCH, SETH SKAHLER, CHRISTOPHER W.KOECH, EMILYSHUTER, JONATHAN | UNIVERSITY OF CHICAGO, IL | $728,006 | HIBI |
| 2024 | Personalized Risk-based Follow-up of Cervical Cancer Screening in Practice (PREDICT)1R01CA288530-01 · under PAR-21-035 | ATLAS, STEVEN JHAAS, JENNIFER S | MASSACHUSETTS GENERAL HOSPITAL, MA | $723,513 | ZRG1 |
| 2024 | Mosaic: RCT of a Digital Health Intervention Delivering Peer Support Narratives and Psychoeducation to English- and Spanish-Speaking Stem Cell Transplant Recipients1R01CA292116-01 · under PAR-21-035 | RINI, CHRISTINE | NORTHWESTERN UNIVERSITY AT CHICAGO, IL | $716,911 | BMHO |
| 2024 | Colorectal Cancer Screening with Optical Coherence Tomography1R01CA280972-01A1 · under PAR-21-035 | TEARNEY, GUILLERMO J | MASSACHUSETTS GENERAL HOSPITAL, MA | $710,880 | ITD |
| 2024 | Randomized controlled trial of FoRtitude: Targeted eHealth intervention to reduce fear of recurrence among breast cancer survivors in community oncology settings1R01CA282682-01A1 · under PAR-21-035 | WAGNER, LYNNE I. | UNIV OF NORTH CAROLINA CHAPEL HILL, NC | $709,050 | BMHO |
| 2024 | Evaluation of a Novel mHealth Intervention for People Who Are Ambivalent About Quitting Smoking: A Randomized Controlled Trial1R01CA293229-01 · under PAR-21-035 | HEFFNER, JAIMEEMCCLURE, JENNIFER B | KAISER FOUNDATION RESEARCH INSTITUTE, CA | $707,367 | IPTA |
| 2024 | A hybrid effectiveness-implementation trial to integrate precision skin cancer risk feedback in federally qualified health centers1R01CA291735-01 · under PAR-21-035 | HAY, JENNIFER LKANETSKY, PETER A | H. LEE MOFFITT CANCER CTR & RES INST, FL | $706,771 | HSQE |
| 2024 | FITting noninvasive testing into Lynch syndrome colorectal cancer surveillance: a multicenter, prospective trial1R01CA287257-01 · under PAR-21-035 | KASTRINOS, FAYKUPFER, SONIASTOFFEL, ELENA MARTINEZ | UNIVERSITY OF CHICAGO, IL | $701,911 | HSQE |
| 2024 | Addressing financial hardship in adolescent and young adult cancer survivors: Efficacy and implementation of a multilevel intervention in community-based oncology practices1R01CA282653-01A1 · under PAR-21-035 | BIRKEN, SARAH ABIGAILSALSMAN, JOHN | WAKE FOREST UNIVERSITY HEALTH SCIENCES, NC | $699,517 | HPC |
| 2024 | Integrating Breast Cancer and Cardiovascular Disease Risk to Explore Decision-Making for Chemoprevention Among Racially/Ethnically Diverse Women at High Risk for Breast Cancer1R01CA293927-01 · under PAR-21-035 | CREW, KATHERINE DKUKAFKA, RITA | COLUMBIA UNIVERSITY HEALTH SCIENCES, NY | $684,333 | ZRG1 |
| 2024 | Symptom Monitoring using Patient-Reported Outcomes to Optimize Medication Use (SyMPTOM)1R01CA285925-01A1 · under PAR-21-035 | FLYNN, KATHRYN ENEUNER, JOAN MARIE | MEDICAL COLLEGE OF WISCONSIN, WI | $678,927 | ICSC |
| 2024 | Prebiotic diet intervention to enhance the microbiome and immunotherapy response in melanoma1R01CA291965-01 · under PAR-21-035 | DANIEL-MACDOUGALL, CARRIEMCQUADE, JENNIFER LEIGHWARGO, JENNIFER A. | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | $678,399 | CONC |
| 2024 | weSipSmarter: An efficacy trial to reduce sugary beverages among rural Head Start parent-child dyads1R01CA282436-01A1 · under PAR-21-035 | ZOELLNER, JAMIE | UNIVERSITY OF VIRGINIA, VA | $670,209 | LCBH |
| 2024 | Expanding access to colorectal cancer screening through community pharmacies: The PharmFIT study1R01CA279010-01A1 · under PAR-21-035 | BRENNER, ALISON TSHAH, PARTH D | UNIV OF NORTH CAROLINA CHAPEL HILL, NC | $666,969 | HSQE |
| 2024 | Symptom Management and Transitioning to Engagement with Post-treatment Care for Adolescent and Young Adult Cancer Survivors (AYA STEPS)1R37CA283353-01A1 · under PAR-21-035 | DORFMAN, CAROLINE | DUKE UNIVERSITY, NC | $664,259 | ICSC |
| 2024 | Testing Oral Nicotine Pouches to Reduce Smoking-Related Cancer Disparities in Appalachia1R01CA289551-01 · under PAR-21-035 | KELLER-HAMILTON, BRITTNEY LWAGENER, THEODORE LEE | OHIO STATE UNIVERSITY, OH | $661,139 | IPTA |
| 2024 | Randomized Trial to Improve Care of Patients with Hereditary Cancer Syndromes1R01CA283332-01A1 · under PAR-21-035 | O'CONNOR, PATRICK J | HEALTHPARTNERS INSTITUTE, MN | $657,621 | ZRG1 |
| 2024 | Strategies for Personalizing Oxygen and support Therapies for dyspnea in Oncology1R01CA288515-01 · under PAR-21-035 | HUI, DAVID | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | $655,203 | ICSC |
| 2024 | Efficacy Trial of Healthy Juntos: A Family-based Digital Lifestyle Intervention for Hispanic Adolescents and their Parents1R01CA289519-01 · under PAR-21-035 | ST. GEORGE, SARA MIJARES | UNIVERSITY OF MIAMI SCHOOL OF MEDICINE, FL | $650,412 | LCBH |
| 2024 | Acceptance and Commitment Therapy for Patient Fatigue Interference and Caregiver Burden in Advanced Gastrointestinal Cancer1R01CA289486-01 · under PAR-21-035 | MOSHER, CATHERINE E | INDIANA UNIVERSITY INDIANAPOLIS, IN | $645,910 | BMHO |
| 2024 | Evaluating a Multilevel Intervention to Increase Colonoscopic Follow-up after Abnormal Stool-based Colorectal Cancer Screening in a Community Safety-Net Setting1R01CA292236-01 · under PAR-21-035 | GLENN, BETH A.MAY, FOLASADE POPOOLA | UNIVERSITY OF CALIFORNIA LOS ANGELES, CA | $622,913 | HSQE |
| 2024 | Alternative Nicotine Delivery Systems as Potential Harm Reduction Tools for Persistent Cigarette Smokers1R01CA290541-01A1 · under PAR-21-035 | AUDRAIN-MCGOVERN, JANET E | UNIVERSITY OF PENNSYLVANIA, PA | $620,313 | ARM |
| 2024 | BMT-CARE: Multimodal Psychosocial Intervention for Caregivers of Patients Undergoing Hematopoietic Stem Cell Transplantation1R01CA282182-01A1 · under PAR-21-035 | EL-JAWAHRI, AREEJJACOBS, JAMIE MICHELE | MASSACHUSETTS GENERAL HOSPITAL, MA | $619,062 | ICSC |
| 2024 | The role of flavor in the substitutability of e-cigarettes for combustible cigarettes among persistent smokers1R01CA287474-01 · under PAR-21-035 | AUDRAIN-MCGOVERN, JANET E | UNIVERSITY OF PENNSYLVANIA, PA | $613,178 | ARM |
| 2024 | Multilevel RCT of Rural Community Sun Safety for Young Children in Sports1R01CA282219-01A1 · under PAR-21-035 | TERCYAK, KENNETHWU, YELENA PING | UNIVERSITY OF UTAH, UT | $604,703 | HPC |
| 2024 | Randomized controlled trial of varenicline to treat tobacco and cannabis co-use.1R01CA290842-01A1 · under PAR-21-035 | MCCLURE, ERIN A | MEDICAL UNIVERSITY OF SOUTH CAROLINA, SC | $602,786 | IPTA |
| 2024 | Title: Multi-Site Randomized Controlled Trial of a Novel Digital Application (SHIFT) to Improve Outcomes for Hematopoietic Stem Cell Transplant Survivors1R01CA295109-01 · under PAR-21-035 | EL-JAWAHRI, AREEJ | MASSACHUSETTS GENERAL HOSPITAL, MA | $602,526 | BMHO |
| 2024 | Effects of a telehealth exercise program for rural cancer survivors with cancer-related fatigue including integrated longitudinal assessments of objective physical function and fatty acid oxidation1R01CA292482-01 · under PAR-21-035 | MARKER, RYAN J | UNIVERSITY OF COLORADO DENVER, CO | $594,734 | CMGC |
| 2024 | Communicating for Health Equity in Digital Environments1R01CA289552-01 · under PAR-21-035 | POPOVA, LYUDMILA | GEORGIA STATE UNIVERSITY, GA | $593,747 | ZRG1 |
| 2024 | A Pragmatic Randomized Controlled Trial to Evaluate the Effectiveness of an Intervention to Promote Guideline-Concordant Colorectal Cancer Surveillance1R01CA293394-01 · under PAR-21-035 | HAWLEY, SARAH TVEENSTRA, CHRISTINE | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | $591,691 | ZRG1 |
| 2024 | Multi-Site Randomized Controlled Trial of a Novel Digital Application (DREAMLAND) to Improve Outcomes for Patients with Acute Myeloid Leukemia1R01CA288550-01 · under PAR-21-035 | EL-JAWAHRI, AREEJ | MASSACHUSETTS GENERAL HOSPITAL, MA | $591,372 | ICSC |
| 2024 | Engage: A Randomized Controlled Trial Testing the Efficacy of a Telehealth-Delivered Psychosocial Intervention to Decrease Symptom Interference in Patients with Advanced Cancer1R01CA291768-01 · under PAR-21-035 | WINGER, JOSEPH GILES | DUKE UNIVERSITY, NC | $578,467 | BMHO |
| 2024 | mHealth Intervention to Support Symptom Communication for Children with Cancer1R01CA291977-01 · under PAR-21-035 | LINDER, LAURI A | UNIVERSITY OF UTAH, UT | $564,300 | CIDH |
| 2024 | Randomized Controlled Trial of a Hybrid-Delivered Cognitive Behavioral Symptom Management and Activity Coaching Intervention for Stem Cell Transplant Patients1R01CA291888-01 · under PAR-21-035 | KELLEHER, SARAH | DUKE UNIVERSITY, NC | $561,734 | ZRG1 |
| 2024 | Misoprostol to Optimize Prevention of Cancer of the Cervix: A Randomized Trial (MISOPCx Project)1R01CA279021-01A1 · under PAR-21-035 | HUH, WARNER KINGMANGA, SIMON | UNIVERSITY OF ALABAMA AT BIRMINGHAM, AL | $561,565 | HSQE |
| 2024 | Lymphedema Prevention Through Immediate Lymphatic Reconstruction1R01CA292908-01 · under PAR-21-035 | ALDRICH, MELISSA BSCHAVERIEN, MARK V | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | $516,114 | IVPP |
| 2024 | Mindfulness Meditation for Younger Breast Cancer Survivors: Testing Digital Interventions in Clinical and Community Settings1R01CA282416-01A1 · under PAR-21-035 | BOWER, JULIENNE EGANZ, PATRICIA A. | UNIVERSITY OF CALIFORNIA LOS ANGELES, CA | $515,404 | CMGC |
| 2024 | Promoting Effective Clinical Communication about Sexual Health after Gynecologic Cancer: A Randomized Controlled Trial of a Patient-Focused Intervention1R01CA285674-01A1 · under PAR-21-035 | REESE, JENNIFER BARSKY | RESEARCH INST OF FOX CHASE CAN CTR, PA | $475,317 | BMHO |
| 2024 | Meaning-Centered Psychotherapy to Meet Palliative Care Needs of Cancer Caregivers1R01CA285621-01 · under PAR-21-035 | APPLEBAUM, ALLISON | SLOAN-KETTERING INST CAN RESEARCH, NY | $195,866 | SPIP |
| 2024 | Hybrid Trial of a Tailored Smoking Cessation Digital Therapeutic for Persons Living with HIV1R01CA285331-01A1 · under PAR-21-035 | ASHARE, REBECCAVILARDAGA, ROGER | DUKE UNIVERSITY, NC | $1 | ZRG1 |
| 2023 | Chicago Alternative Prevention Study for BReast CAncer in Diverse Populations of High-Risk Women (CAPSBRACA)1R01CA276652-01A1 · under PAR-21-035 | ABE, HIROYUKIKARCZMAR, GREGORY S.OLOPADE, OLUFUNMILAYO F. | UNIVERSITY OF CHICAGO, IL | $1,268,206 | CIDH |
| 2023 | Screening strategies and social determinants of health among people with high risk of anal cancer1R01CA285198-01 · under PAR-21-035 | FLOWERS, LISA C.ROSA-CUNHA, ISABELLAXIAO, CANHUA | EMORY UNIVERSITY, GA | $1,046,509 | HCCS |
| 2023 | Immunoglobulin Replacement Therapy and Infectious Complications After CD19-Targeted CAR-T-Cell Therapy1R01CA276040-01A1 · under PAR-21-035 | HILL, JOSHUA AIDENPERALES, MIGUEL-ANGEL | FRED HUTCHINSON CANCER CENTER, WA | $930,383 | CONC |
| 2023 | Bionic Breast Project: A Neuroprosthesis to Restore Touch Sensation and Reduce Chronic Pain After Mastectomy1R01CA281301-01A1 · under PAR-21-035 | LINDAU, STACY TESSLER | UNIVERSITY OF CHICAGO, IL | $844,117 | BNVT |
| 2023 | Refer 2 Quit: Proactive Promotion of Tobacco Use Treatment for Underserved Household Members Who Smoke through Pediatric Primary Care1R37CA282153-01 · under PAR-21-035 | JENSSEN, BRIAN P. | CHILDREN'S HOSP OF PHILADELPHIA, PA | $779,874 | IPTA |
| 2023 | Re-Engaging AYA Survivors in Cancer-Related Healthcare (REACH): A Sequential Multiple Assignment Randomized Trial (SMART)1R01CA273328-01A1 · under PAR-21-035 | SCHWARTZ, LISA A | CHILDREN'S HOSP OF PHILADELPHIA, PA | $756,425 | ICSC |
| 2023 | A Type I Hybrid Effectiveness-Implementation Trial to Evaluate a Navigation-Based Multilevel Intervention to Decrease Delays Starting Adjuvant Therapy Among Patients with Head and Neck Cancer1R01CA282165-01 · under PAR-21-035 | GRABOYES, EVAN MICHAEL | MEDICAL UNIVERSITY OF SOUTH CAROLINA, SC | $751,693 | HSQE |
| 2023 | Using a SMART design to evaluate remotely delivered, culturally tailored weight loss interventions among Latina breast cancer survivors1R01CA270441-01A1 · under PAR-21-035 | GREENLEE, HEATHER | FRED HUTCHINSON CANCER CENTER, WA | $747,975 | LCBH |
| 2023 | Trial of a harm reduction strategy for people with HIV who smoke cigarettes1R01CA275521-01A1 · under PAR-21-035 | SHUTER, JONATHAN | ALBERT EINSTEIN COLLEGE OF MEDICINE, NY | $745,331 | HIBI |
| 2023 | Digital smoking cessation intervention for nationally-recruited American Indians and Alaska Natives: A full-scale randomized controlled trial1R01CA284687-01A1 · under PAR-21-035 | BRICKER, JONATHAN B | FRED HUTCHINSON CANCER CENTER, WA | $744,186 | HPC |
| 2023 | Implementing the NYU Electronic Patient Visit Assessment (ePVA) for Head and Neck Cancer In Rural and Urban Populations1R01CA282149-01 · under PAR-21-035 | VAN CLEAVE, JANET H | UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON, TX | $733,528 | ZRG1 |
| 2023 | Intermittent Fasting using a Fasting-Mimetic Diet to Improve Prostate Cancer Control and Metabolic Outcomes1R01CA280081-01 · under PAR-21-035 | DORFF, TANYAFREEDLAND, STEPHEN JAYLIN, PAO-HWA | CEDARS-SINAI MEDICAL CENTER, CA | $722,345 | CPSS |
| 2023 | Randomized clinical trial to test the efficacy of a smartphone app for smoking cessation for nondaily smokers1R01CA282223-01 · under PAR-21-035 | HOEPPNER, BETTINA B. | MASSACHUSETTS GENERAL HOSPITAL, MA | $706,777 | IPTA |
| 2023 | Optimizing psychosocial intervention for breast cancer-related sexual morbidity: A factorial trial using the National Cancer Institute Community Oncology Research Program (NCORP) network1R37CA269776-01A1 · under PAR-21-035 | SHAFFER, KELLY MCLEAN | UNIVERSITY OF VIRGINIA, VA | $705,130 | BMHO |
| 2023 | Psycho-Spiritual Management for Patients with Advanced Cancer and their Family Caregivers1R01CA276035-01A1 · under PAR-21-035 | MILBURY, KATHRIN | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | $694,107 | ICSC |
| 2023 | Multisite Implementation of COMPRENDO (ChildhOod Malignancy Peer REsearch NavigatiOn) to improve participation of Hispanic children in cancer clinical trials1R01CA279945-01 · under PAR-21-035 | ARISTIZABAL, PAULA | UNIVERSITY OF CALIFORNIA, SAN DIEGO, CA | $692,684 | HHD |
| 2023 | Digital Self-Management and Peer Mentoring Intervention to Improve the Transition from Pediatric to Adult Health Care for Childhood Cancer Survivors1R01CA282147-01 · under PAR-21-035 | DEVINE, KATIE A | RUTGERS BIOMEDICAL AND HEALTH SCIENCES, NJ | $690,045 | CMGC |
| 2023 | Managing symptoms and psychological distress during oral anti-cancer treatment1R01CA279472-01 · under PAR-21-035 | BADGER, TERRY ACRANE, TRACY ESIKORSKII, ALLA | MICHIGAN STATE UNIVERSITY, MI | $689,739 | BMHO |
| 2023 | The impact of cannabis and tobacco/nicotine product co-use in young adults: Prospective cessation evaluation and substitution1R01CA276066-01A1 · under PAR-21-035 | MCCLURE, ERIN A | MEDICAL UNIVERSITY OF SOUTH CAROLINA, SC | $689,656 | ZRG1 |
| 2023 | Epigallocatechin gallate for prevention of lethal cirrhosis complications1R01CA282178-01 · under PAR-21-035 | HOSHIDA, YUJINSINGAL, AMIT | UT SOUTHWESTERN MEDICAL CENTER, TX | $684,526 | HBPP |
| 2023 | Optimizing a Social Connectedness Intervention for Young Adults with Cancer1R01CA276176-01A1 · under PAR-21-035 | FREDRICKSON, BARBARA LEELAZARD, ALLISON JOAN | UNIV OF NORTH CAROLINA CHAPEL HILL, NC | $680,456 | SPIP |
| 2023 | The Effects of Treating Insomnia on Behavioral Weight Loss Outcomes in Survivors of Breast Cancer1R01CA281220-01 · under PAR-21-035 | SMITH, MICHAEL TWILDER COUGHLIN, JANELLE | JOHNS HOPKINS UNIVERSITY, MD | $679,559 | LCBH |
| 2023 | A Biobehavioral Intervention to Reduce Adverse Outcomes in Young Adult Testicular Cancer Survivors1R01CA276143-01A1 · under PAR-21-035 | HOYT, MICHAEL A | UNIVERSITY OF CALIFORNIA-IRVINE, CA | $672,977 | BMHO |
| 2023 | A Randomized Controlled Trial to Improve Health Insurance Literacy and Surveillance among Young Adult Cancer Survivors1R01CA276825-01A1 · under PAR-21-035 | KIRCHHOFF, ANNE CPARK, ELYSE R. | UNIVERSITY OF UTAH, UT | $672,704 | ICSC |
| 2023 | Optimization of a personalized skin cancer risk intervention for at-risk young adults1R01CA266302-01A1 · under PAR-21-035 | HAY, JENNIFER LWU, YELENA PING | UNIVERSITY OF UTAH, UT | $671,963 | ZRG1 |
| 2023 | Opioid-Sparing Effects of Nurse-Delivered Hypnosis During Breast Cancer Surgery1R01CA272565-01A1 · under PAR-21-035 | COHEN, LORENZO | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | $669,504 | ICSC |
| 2023 | PREVENT - Practice-based Approaches to Promote HPV Vaccination1R01CA279973-01 · under PAR-21-035 | KEPKA, DEANNA LEE | UNIVERSITY OF UTAH, UT | $666,739 | SIHH |
| 2023 | Understanding and addressing rejection of personalized cancer risk information1R01CA279953-01 · under PAR-21-035 | SCHERER, LAURA D.WATERS, ERIKA A | UNIVERSITY OF COLORADO DENVER, CO | $660,513 | SPIP |
| 2023 | Providing Tobacco Treatment to Patients Undergoing Lung Cancer Screening at MedStar Health: A Randomized Trial1R01CA274716-01A1 · under PAR-21-035 | TAYLOR, KATHRYN L | GEORGETOWN UNIVERSITY, DC | $660,333 | HSQE |
| 2023 | A Randomized Controlled Trial to Evaluate a Novel Treatment Strategy for Body Image-Related Distress Among Head and Neck Cancer Survivors1R37CA269385-01A1 · under PAR-21-035 | GRABOYES, EVAN MICHAEL | MEDICAL UNIVERSITY OF SOUTH CAROLINA, SC | $658,153 | LCBH |
| 2023 | Effectiveness of Out-of-Pocket Cost COMmunication and Financial Navigation (CostCOM) in Cancer Patients1R01CA272680-01 · under PAR-21-035 | SADIGH, GELAREH | UNIVERSITY OF CALIFORNIA-IRVINE, CA | $652,687 | ODHS |
| 2023 | Evaluating a remotely delivered, digital health CRC screening intervention among racially diverse patients of a community health center1R01CA273331-01A1 · under PAR-21-035 | FRERICHS, LEAH M. | UNIV OF NORTH CAROLINA CHAPEL HILL, NC | $650,993 | CMGC |
| 2023 | Cannabis for Palliative Care in Cancer: A Placebo-controlled Randomized Trial of Full Spectrum Hemp-derived CBD/THC1R01CA284860-01 · under PAR-21-035 | BRYAN, ANGELAHUTCHISON, KENT E. | UNIVERSITY OF COLORADO, CO | $650,978 | BMHO |
| 2023 | Efficacy and implementation of exercise-based smoking cessation treatment for adults with high anxiety sensitivity1R01CA273221-01A1 · under PAR-21-035 | CHENEY, MARSHALLSMITS, JASPERZVOLENSKY, MICHAEL J. | UNIVERSITY OF TEXAS AT AUSTIN, TX | $648,024 | IPTA |
| 2023 | Using Tailored mHealth Strategies to Promote Weight Management among Adolescent and Young Adult Cancer Survivors1R01CA270111-01A1 · under PAR-21-035 | LAROSE, JESSICA GOKEEVALLE, CARMINA G | UNIV OF NORTH CAROLINA CHAPEL HILL, NC | $647,947 | LCBH |
| 2023 | Cognitive Training for Cancer-related Cognitive Impairment: A Multi-Center Randomized Controlled Trial1R01CA276222-01 · under PAR-21-035 | GANZ, PATRICIA A.MCDONALD, BRENNA CVON AH, DIANE MARIE | OHIO STATE UNIVERSITY, OH | $639,125 | BMHO |
| 2023 | Community Services Navigation to Advance Health Equity in Breast Cancer Screening1R01CA282409-01 · under PAR-21-035 | ONEGA, TRACYOZANNE, ELISSA MARY | UNIVERSITY OF UTAH, UT | $638,074 | HHD |
| 2023 | Testing the efficacy of a decision aid and planning tool for family building after cancer1R37CA282148-01 · under PAR-21-035 | BENEDICT, CATHERINE | STANFORD UNIVERSITY, CA | $632,887 | CMGC |
| 2023 | Evaluation of a telehealth oncofertility care intervention in adolescent and young adult cancer patients: a stepped wedge cluster randomized controlled trial1R01CA271104-01A1 · under PAR-21-035 | SU, HUI-CHUN IRENE | UNIVERSITY OF CALIFORNIA, SAN DIEGO, CA | $632,351 | ICSC |
| 2023 | A clinical trial of adaptive treatment for early smoking cessation relapse1R01CA284649-01 · under PAR-21-035 | CARPENTER, MATTHEW JSMITH, TRACY TAYLOR | MEDICAL UNIVERSITY OF SOUTH CAROLINA, SC | $622,093 | IPTA |
| 2023 | Evaluating an evidence-based family history screening program adapted to increase reach and uptake of screening for BRCA-associated cancers in rural public health clinics1R37CA276317-01A1 · under PAR-21-035 | GUAN, YUE | EMORY UNIVERSITY, GA | $615,683 | HSQE |
| 2023 | Secondary Cervical Cancer Prevention of Vulnerable Women with HPV and HIV Co-infection in India1R01CA285063-01 · under PAR-21-035 | CARPENTER, CATHERINE LNYAMATHI, ADELINE MSATYANARAYANA, VEENA A | UNIVERSITY OF CALIFORNIA-IRVINE, CA | $610,339 | HIBI |
| 2023 | Randomized Controlled Trial of Dyadic Financial Incentive Treatment for Dual Smoker Couples: Evaluation of Efficacy, Mechanisms, and Cost Effectiveness1R01CA276594-01A1 · under PAR-21-035 | VANDELLEN, MICHELLE RENEE | UNIVERSITY OF GEORGIA, GA | $606,831 | IPTA |
| 2023 | Internet-Based Lifestyle Intervention to Eradicate Obese Frailty in Prostate Cancer Survivors (iLIVE)1R01CA275055-01A1 · under PAR-21-035 | DEMARK-WAHNEFRIED, WENDYWINTERS-STONE, KERRI M | OREGON HEALTH & SCIENCE UNIVERSITY, OR | $587,585 | LCBH |
| 2023 | Strategies for Optimizing a Mailed FIT Program in Appalachia1R01CA282162-01 · under PAR-21-035 | KATZ, MIRA LREITER, PAUL L | OHIO STATE UNIVERSITY, OH | $584,251 | HHD |
| 2023 | Replacing Invasive Cystoscopy with Urine Testing for Non-muscle Invasive Bladder Cancer Surveillance1R37CA275916-01 · under PAR-21-035 | SCHROECK, FLORIAN R | VETERANS EDUCATION/RES/ASSN/NORTH/NE, VT | $583,892 | ZRG1 |
| 2023 | Implementing and Evaluating the Cancer Tracking System (CATSystem): A systems level intervention to improve Cervical Cancer screening, treatment referral and follow up in Kenya1R01CA278617-01A1 · under PAR-21-035 | KESSLER, SARAH FINOCCHARIOMABACHI, MARIANNE NATABHONA | UNIVERSITY OF KANSAS MEDICAL CENTER, KS | $583,607 | PPAH |
| 2023 | The effectiveness, cost-effectiveness, and budget impact of interventions to improve the delivery of cervical cancer screening in Puerto Rico.1R01CA282424-01 · under PAR-21-035 | DESHMUKH, ASHISH A.ORTIZ, ANA PATRICIA | COMPREHENSIVE CANCER CENTER/ UNIV/PR, PR | $566,891 | ODHS |
| 2023 | A dyadic exercise approach to prevent declines in physical and mental health in couples during radiation treatment for cancer: a hybrid type I efficacy-implementation trial1R01CA277738-01A1 · under PAR-21-035 | WINTERS-STONE, KERRI M | OREGON HEALTH & SCIENCE UNIVERSITY, OR | $560,335 | CMGC |
| 2022 | Promoting Resilience in Early Survivorship among Adolescents and Young Adults with Cancer.1R01CA269574-01 · under PAR-21-035 | ROSENBERG, ABBY RYI-FRAZIER, JOYCE P | SEATTLE CHILDREN'S HOSPITAL, WA | $930,291 | LCBH |
| 2022 | Pelvic fascia spARing radical prostatectomy TrIAL (PARTIAL)1R01CA259173-01A1 · under PAR-21-035 | ALLAF, MOHAMADHU, JIMKOWALCZYK, KEITHSCHAEFFER, EDWARD MATTHEW | WEILL MEDICAL COLL OF CORNELL UNIV, NY | $733,721 | CONC |
| 2022 | Systematic Light Exposure Effects on Circadian Rhythms Entrainment, Inflammation, Neutropenic Fever and Symptom Burden among Multiple Myeloma Patients undergoing Autologous Stem Cell Transplantation1R01CA260961-01A1 · under PAR-21-035 | FIGUEIRO, MARIANA GROSSVALDIMARSDOTTIR, HEIDDIS | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NY | $728,085 | MESH |
| 2022 | Randomized Trial of Exercise Therapy on Markers of Progression in Localized Prostate Cancer:1R01CA272678-01 · under PAR-21-035 | BOUTROS, PAUL CHRISTOPHERJONES, LEE W | SLOAN-KETTERING INST CAN RESEARCH, NY | $715,452 | LCBH |
| 2022 | Provider Support and Patient Outreach in Lung Cancer Screening1R01CA258849-01A1 · under PAR-21-035 | MYERS, RONALD E. | THOMAS JEFFERSON UNIVERSITY, PA | $713,095 | CMGC |
| 2022 | The Impact of Standardized Tobacco Product Packaging on Young Adults in the Retail Environment1R01CA261639-01A1 · under PAR-21-035 | SHADEL, WILLIAM G | RAND CORPORATION, CA | $711,244 | CIHB |
| 2022 | A behavioral economic intervention for low-income smokers1R37CA252483-01A1 · under PAR-21-035 | ROGERS, ERIN | NEW YORK UNIVERSITY SCHOOL OF MEDICINE, NY | $688,443 | HPC |
| 2022 | Novel Therapy to Inhibit IPMN Progression1R01CA263575-01A1 · under PAR-21-035 | BATRA, SURINDER K.MALAFA, MOKENGE P. | H. LEE MOFFITT CANCER CTR & RES INST, FL | $686,204 | CONC |
| 2022 | Using real-time data capture to examine affective mechanisms as mediators of physical activity adherence in interventions1R01CA272933-01 · under PAR-21-035 | DUNTON, GENEVIEVE FRIDLUND | UNIVERSITY OF SOUTHERN CALIFORNIA, CA | $684,743 | SPIP |
| 2022 | A randomized controlled trial of eSCCIP: An eHealth psychosocial intervention for English and Spanish speaking parents of children with cancer1R01CA258668-01A1 · under PAR-21-035 | CANTER, KIMBERLY | NEMOURS CHILDREN'S HOSPITAL, DELAWARE, DE | $683,323 | CMGC |
| 2022 | Psilocybin Therapy for Advanced Cancer-related Psychiatric Distress1R01CA268521-01A1 · under PAR-21-035 | FISCHER, STACY MROSS, STEPHEN | NEW YORK UNIVERSITY SCHOOL OF MEDICINE, NY | $681,645 | BMHO |
| 2022 | Improving medication adherence using a CONnected CUstomized Treatment Platform (CONCURxP)1R01CA262312-01A1 · under PAR-21-035 | GRAETZ, ILANASADIGH, GELAREH | UNIVERSITY OF CALIFORNIA-IRVINE, CA | $678,579 | ZRG1 |
| 2022 | Behavioral Economic Approaches for Population-based Colorectal Cancer Screening1R01CA258893-01A1 · under PAR-21-035 | MEHTA, SHIVAN JATIN | UNIVERSITY OF PENNSYLVANIA, PA | $672,627 | HSQE |
| 2022 | Using Multiphase Optimization Strategy (MOST) to Optimize a Cost-effective, Sustainable and Scalable Smoking Cessation Package for Smokers in HIV Clinical Care1R01CA268932-01A1 · under PAR-21-035 | CANTRELL, JENNIFER | NEW YORK UNIVERSITY, NY | $668,411 | HIBI |
| 2022 | A digital intervention to improve skin self-examination among melanoma survivors1R01CA264548-01A1 · under PAR-21-035 | HECKMAN, CAROLYNMANNE, SHARON L | RBHS -CANCER INSTITUTE OF NEW JERSEY, NJ | $664,230 | SIHH |
| 2022 | REmotely-delivered Supportive Programs for Improving surgical pain and disTrEss (RESPITE)1R01CA266995-01A1 · under PAR-21-035 | SOHL, STEPHANIE JEAN | WAKE FOREST UNIVERSITY HEALTH SCIENCES, NC | $659,522 | BMHO |
| 2022 | Fit2ThriveMIND: Optimizing a mHealth Physical Activity Intervention with Mindful Awareness Lessons in Breast Cancer Survivors1R01CA266178-01A1 · under PAR-21-035 | PHILLIPS, SIOBHAN MARIEVICTORSON, DAVID | NORTHWESTERN UNIVERSITY AT CHICAGO, IL | $655,828 | ZRG1 |
| 2022 | Empowering Latinas to Obtain Guideline-Concordant Breast Cancer Screenings1R01CA261638-01A1 · under PAR-21-035 | MOLINA, YAMILE | UNIVERSITY OF ILLINOIS AT CHICAGO, IL | $655,642 | HPC |
| 2022 | Improving smoking abstinence outcomes in the African American community through extended treatment1R01CA259256-01A1 · under PAR-21-035 | COX, LISA SANDERSON | UNIVERSITY OF KANSAS MEDICAL CENTER, KS | $655,179 | ARM |
| 2022 | Web-based Pain Coping Skills Training to Improve Pain and Poor Adherence caused by Aromatase Inhibitor-Associated Arthralgia In Breast Cancer Survivors (SKIP-Arthralgia): A Randomized Controlled Trial1R01CA271220-01 · under PAR-21-035 | RINI, CHRISTINE | NORTHWESTERN UNIVERSITY AT CHICAGO, IL | $653,640 | ZRG1 |
| 2022 | Novel Health Equity Intervention to Improve Pediatric Oncology Outcome Disparities: Targeting Poverty and Psychosocial Stress1R01CA267107-01 · under PAR-21-035 | BONA, KIRA O.ROSENBERG, ABBY R | DANA-FARBER CANCER INST, MA | $651,395 | SPIP |
| 2022 | Adaptive Symptom Self-Management to Reduce Psychological Distress and Improve Symptom Management for Survivors on Immune Checkpoint Inhibitors1R01CA263714-01A1 · under PAR-21-035 | BADGER, TERRY ASIKORSKII, ALLA | UNIVERSITY OF ARIZONA, AZ | $650,104 | BMHO |
| 2022 | Hybrid Type 1 Effectiveness-Implementation Trial of a Proactive Smoking Cessation Electronic Visit for Scalable Delivery via Primary Care1R01CA258669-01A1 · under PAR-21-035 | DAHNE, JENNIFER RENEE | MEDICAL UNIVERSITY OF SOUTH CAROLINA, SC | $649,204 | SIHH |
| 2022 | Multilevel health system intervention to increase surveillance colonoscopy for high-risk colorectal polyps1R01CA271034-01 · under PAR-21-035 | MAY, FOLASADE POPOOLA | UNIVERSITY OF CALIFORNIA LOS ANGELES, CA | $647,435 | HSQE |
| 2022 | High-dose Vitamin D Supplementation for ADT-Induced Bone Loss in Older Prostate Cancer Patients1R01CA258349-01A1 · under PAR-21-035 | PEPPONE, LUKE JOSEPH | UNIVERSITY OF ROCHESTER, NY | $635,824 | ICSC |
| 2022 | Targeted Prevention of Postpartum-Related Breast Cancer (PRBC)1R01CA262393-01A1 · under PAR-21-035 | RADISKY, DEREK CRUDDY, KATHRYN JEANSHERMAN, MARK E | MAYO CLINIC JACKSONVILLE, FL | $627,061 | CPSS |
| 2022 | Early clinial trials for Angelica herbal supplements for prostate cancer interception1R01CA260901-01A1 · under PAR-21-035 | JOSHI, MONIKALU, JUNXUAN | PENNSYLVANIA STATE UNIV HERSHEY MED CTR, PA | $623,285 | CPSS |
| 2022 | Novel dietary interventions for reducing obesity-associated breast cancer1R01CA258766-01A1 · under PAR-21-035 | CATENACCI, VICTORIA AKABOS, PETERMACLEAN, PAUL S. | UNIVERSITY OF COLORADO DENVER, CO | $606,900 | CPSS |
| 2022 | Formulation, Evaluation, and Phase 0 Trial of Nanoparticle Releasing Oral Thin Film for OSCC Chemoprevention1R01CA258757-01A1 · under PAR-21-035 | MALLERY, SUSAN R | OHIO STATE UNIVERSITY, OH | $581,591 | CPSS |
| 2022 | Pioglitazone-Metformin Combination Treatment for High Risk Oral Preneoplasia1R01CA254270-01A1 · under PAR-21-035 | ONDREY, FRANK G. | UNIVERSITY OF MINNESOTA, MN | $321,566 | CPSS |
| 2022 | Consumer-based meditation app, Calm, for treatment of sleep disturbance in hematological cancer patients1R01CA262041-01A1 · under PAR-21-035 | HUBERTY, JENNIFER LYNNEMESA, RUBEN A. | CALM.COM, INC., CA | $95,759 | MESH |
| 2021 | Remote Monitoring of Management of Chemotherapy induced Peripheral Neuropathy1R01CA247517-01A1 · under PAR-18-559 | KOLB, NOAH ALLANMOONEY, KATHLEEN HSMITH, A. GORDON | UNIVERSITY OF VERMONT & ST AGRIC COLLEGE, VT | $1,170,573 | CMPC |
| 2021 | The effectiveness of screening women with lower genital tract neoplasia or cancers for anal cancer precursors1R01CA256660-01A1 · under PAR-18-559 | CHIAO, ELIZABETH Y.DESHMUKH, ASHISH A.SIGEL, KEITH MAGNUS | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NY | $916,003 | HSQE |
| 2021 | Biomarker-Based Phase IIB Trial of (Bazedoxifene-Conjugated Estrogen) to Reduce Risk for Breast Cancer1R01CA249437-01A1 · under PAR-18-559 | FABIAN, CAROL J. | UNIVERSITY OF KANSAS MEDICAL CENTER, KS | $852,459 | CPSS |
| 2021 | RESPECT3: A Randomized type 1 hybrid Effectiveness-implementation Study of returning actionable genetic PanEl researCh resulTs2R01CA190871-06A1 · under PAR-18-559 | BRADBURY, ANGELA R. | UNIVERSITY OF PENNSYLVANIA, PA | $791,997 | ZRG1 |
| 2021 | The ASPIRES Study: Activating Cancer Survivors and their Primary Care Providers to Increase Colorectal Cancer Screening1R01CA255269-01 · under PAR-18-559 | HENDERSON, TARA OLIVEKIM, KAREN E | UNIVERSITY OF CHICAGO, IL | $748,224 | PRDP |
| 2021 | Empathic Communication Skills Training to Reduce Lung Cancer Stigma1R01CA255522-01A1 · under PAR-18-559 | BANERJEE, SMITAOSTROFF, JAMIE S. | SLOAN-KETTERING INST CAN RESEARCH, NY | $734,084 | ICSC |
| 2021 | Multilevel Interventions to Increase Adherence to Lung Cancer Screening1R01CA262015-01 · under PAR-18-559 | WERNLI, KAREN J | KAISER FOUNDATION RESEARCH INSTITUTE, CA | $712,200 | HSQE |
| 2021 | Optimization of a remote intervention to improve nutrition and physical activity in colorectal cancer survivors1R37CA248774-01A1 · under PAR-18-559 | VAN BLARIGAN, ERIN LYNN | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $705,777 | PRDP |
| 2021 | Enhancing the public health benefits of mammography screening by informing women of both breast cancer and breast arterial calcification results: A randomized trial to promote cardiovascular health1R01CA251754-01A1 · under PAR-18-559 | MONTGOMERY, GUY H | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NY | $702,634 | PRDP |
| 2021 | Clinical Utility of Biomarkers Driven Management of Indeterminate Pulmonary Nodules1R01CA252964-01A1 · under PAR-18-559 | BARON, ANNA EGROGAN, ERIC L | VANDERBILT UNIVERSITY MEDICAL CENTER, TN | $700,695 | CONC |
| 2021 | Randomized Controlled Trial of Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes1R01CA252211-01A1 · under PAR-18-559 | IRWIN, SCOTT ASPIEGEL, BRENNAN | CEDARS-SINAI MEDICAL CENTER, CA | $694,136 | BMIO |
| 2021 | Cancer Immune-Interception for Lynch Syndrome1R01CA257375-01 · under PAR-18-559 | LIPKIN, STEVEN MVILAR SANCHEZ, EDUARDO | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | $692,579 | ZRG1 |
| 2021 | Empirical testing of a widely available insurance-based monetary incentive program for exercise: A randomized trial1R01CA262894-01 · under PAR-18-559 | GALARRAGA, OMARWILLIAMS, DAVID M | BROWN UNIVERSITY, RI | $683,723 | LCBH |
| 2021 | Trial of Statins for Chemoprevention in Hepatocellular Carcinoma1R01CA255621-01A1 · under PAR-18-559 | CHUNG, RAYMOND THOSHIDA, YUJIN | MASSACHUSETTS GENERAL HOSPITAL, MA | $675,855 | CPSS |
| 2021 | Identifying modifiable factors that reduce the burden of late stage melanoma in Hispanics1R01CA252182-01A1 · under PAR-18-559 | COCKBURN, MYLES GMILLER, KIMBERLY ANN | UNIVERSITY OF SOUTHERN CALIFORNIA, CA | $675,213 | HDEP |
| 2021 | Promoting HPV Vaccination among Young Adults in Texas1R01CA248216-01A1 · under PAR-18-559 | LU, QIAN | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | $671,898 | CLHP |
| 2021 | Establishing smoke-free homes with families involved in child protective services: An effectiveness-implementation trial of an integrated program1R01CA248551-01A1 · under PAR-18-559 | KEGLER, MICHELLE CSELF-BROWN, SHANNON RENEE | GEORGIA STATE UNIVERSITY, GA | $670,837 | DIRH |
| 2021 | Mediterranean Diet and Weight Loss: Targeting the Bile Acid/Gut Microbiome Axis to Reduce Colorectal Cancer Risk1R01CA250390-01A1 · under PAR-18-559 | FITZGIBBON, MARIAN L.TUSSING-HUMPHREYS, LISA | UNIVERSITY OF ILLINOIS AT CHICAGO, IL | $669,294 | CPSS |
| 2021 | Problem-Solving Therapy for Cancer Caregivers: A Randomized Clinical Trial in Outpatient Palliative Care1R01CA258311-01 · under PAR-18-559 | WASHINGTON, KARLA | WASHINGTON UNIVERSITY, MO | $666,584 | CMPC |
| 2021 | CONNECT: COmpreheNsive traiNing and Engagement in Cessation Treatment1R01CA255016-01A1 · under PAR-18-559 | BAILEY, STEFFANI R | OREGON HEALTH & SCIENCE UNIVERSITY, OR | $660,260 | HPC |
| 2021 | Reducing cervical cancer screening disparities in Somali immigrant women through a primary care based HPV self-sampling intervention1R01CA248558-01A1 · under PAR-18-559 | PRATT, REBEKAH J.WINER, RACHEL L. | UNIVERSITY OF MINNESOTA, MN | $657,387 | DIRH |
| 2021 | Writing to Heal: A Culturally Based Brief Expressive Writing Intervention for Chinese Immigrant Breast Cancer Survivors1R01CA248213-01A1 · under PAR-18-559 | LU, QIAN | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | $657,316 | SPIP |
| 2021 | Acceptance and Commitment Therapy for Fear of Recurrence in Breast Cancer Survivors1R01CA255480-01A1 · under PAR-18-559 | JOHNS, SHELLEY A. | INDIANA UNIVERSITY INDIANAPOLIS, IN | $655,048 | CMGC |
| 2021 | SPHERE (Survivorship Plan Health Record) Implementation Trial1R01CA241143-01A1 · under PAR-18-559 | HAGGSTROM, DAVID ANDREW | INDIANA UNIVERSITY INDIANAPOLIS, IN | $649,730 | DIRH |
| 2021 | Effects of inflammaging on intestinal epithelial cells and aspirin chemoprevention.1R01CA257523-01 · under PAR-18-559 | CHAN, ANDREW TSTAPPENBECK, THADDEUS SYILMAZ, OMER | MASSACHUSETTS GENERAL HOSPITAL, MA | $649,181 | CPSS |
| 2021 | Testing a Clinician and Patient Intervention to Promote smoking Cessation Among Pregnant Women1R01CA247791-01A1 · under PAR-18-559 | CHANG, JUDY CPOLLAK, KATHRYN I | DUKE UNIVERSITY, NC | $648,264 | CMPC |
| 2021 | Efficacy of a self-advocacy serious game intervention for women with advanced cancer1R37CA262025-01 · under PAR-18-559 | THOMAS, TERESA HAGAN | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | $646,893 | BMHO |
| 2021 | Effect of Helpers Program On-line Training on Smoking Relapse and Social Networks1R01CA248658-01A1 · under PAR-18-559 | MURAMOTO, MYRA L. | UNIVERSITY OF ARIZONA, AZ | $645,082 | IPTA |
| 2021 | Mobile Contingency Management for Smoking Cessation among Socioeconomically Disadvantaged Adults1R01CA251451-01A1 · under PAR-18-559 | KENDZOR, DARLA ELIZABETH | UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR, OK | $638,669 | IPTA |
| 2021 | Metformin for chemoprevention of lung cancer in obese subjects at high risk1R01CA255515-01A1 · under PAR-18-559 | BARBI, JOSEPHREID, MARY EYENDAMURI, SAIKRISHNA | ROSWELL PARK CANCER INSTITUTE CORP, NY | $630,457 | CPSS |
| 2021 | Enhancing cognitive function in breast cancer survivors through community-based aerobic exercise training1R37CA252060-01A1 · under PAR-18-559 | EHLERS, DIANE KRISTEN | UNIVERSITY OF NEBRASKA MEDICAL CENTER, NE | $603,299 | BMIO |
| 2021 | An Addictions Neuroclinical Assessment Based Treatment for Smokers with an Alcohol Use Disorder1R01CA252185-01A1 · under PAR-18-559 | MCPHERSON, STERLING M | WASHINGTON STATE UNIVERSITY, WA | $600,704 | IPTA |
| 2021 | Testing a culturally targeted narrative video to reduce disparities in the use of genetic counseling and testing in Latina women at-risk of HBOC1R01CA248543-01A1 · under PAR-18-559 | HURTADO DE MENDOZA CASAUS, ALEJANDRA | GEORGETOWN UNIVERSITY, DC | $596,045 | HDEP |
| 2021 | A Randomized Controlled Trial: Genetic Counseling Patient Preference Intervention via Electronic Health Record Portal vs. Conventional Genetic Counseling for Women at Elevated Risk for Breast Cancer1R01CA248739-01A1 · under PAR-18-559 | KATZ, MIRA LSWEET, KEVIN M. | OHIO STATE UNIVERSITY, OH | $563,458 | ZRG1 |
| 2021 | Evaluating a mobile application to reduce distress in breast cancer survivors using an adaptive design1R37CA248434-01A1 · under PAR-18-559 | CHOW, PHILIP | UNIVERSITY OF VIRGINIA, VA | $518,789 | APDA |
| 2021 | MyGI Diet for Colorectal Cancer Prevention1R01CA255743-01A1 · under PAR-18-559 | BUIS, LORRAINE RDJURIC, ZORA | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | $511,916 | CPSS |
| 2020 | Extending the Diversity, Reach, and Generalizability of the WISDOM Study1R01CA237533-01A1 · under PAR-18-559 | ESSERMAN, LAURA J | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $1,508,351 | CHSA |
Showing the 200 most recent of 288 awards.
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.